GLT8D3 activators are a category of chemical agents specifically designed to modulate the activity of the enzyme GLT8D3, which is a member of the glycosyltransferase family. Glycosyltransferases are enzymes that facilitate the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. This process is crucial for the proper assembly and maintenance of various glycoconjugates, including glycoproteins and glycolipids, which are vital for numerous cellular functions. The activators of GLT8D3 are thought to increase the enzymatic activity, possibly by promoting substrate recognition or catalysis. By enhancing the enzyme's function, these activators can affect the synthesis and structure of glycoconjugates, potentially impacting cell signaling, protein folding, and cellular adhesion.
The specific chemical makeup of GLT8D3 activators would likely include structural motifs that are complementary to the active site or allosteric sites of the enzyme. This complementarity could be achieved through hydrogen bonding, hydrophobic interactions, or van der Waals forces, which would stabilize the enzyme in a conformation that is more conducive to its catalytic action. Finding and optimizing GLT8D3 activators typically involves a combination of in vitro assays to measure enzyme activity, structure-guided design to enhance interaction with the enzyme, and medicinal chemistry strategies to improve the physicochemical properties of these molecules.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly increases cAMP levels, which subsequently stimulates PKA, a kinase that can be involved in pathways leading to GLT8D3 activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the JNK and p38 MAPK pathways, which may directly involve and activate GLT8D3. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an activator of AMPK. Activated AMPK can potentially lead to metabolic changes that necessitate GLT8D3 activation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is an analogue of cAMP, serving to activate PKA-dependent pathways, which could involve GLT8D3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). PKC activation might lead to pathways that require GLT8D3 activation. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
As an activator of AMPK, Metformin can lead to changes in cellular metabolism, which might involve GLT8D3 activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to activate the SIRT1 pathway. It's possible that this pathway has cross-talk or interactions with GLT8D3-associated pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits PDE4, leading to an increase in cAMP levels, which could stimulate pathways leading to GLT8D3 activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate pathways related to cell differentiation and might have a role in pathways leading to GLT8D3 activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K-Akt pathway, which, while a growth-promoting pathway, may also play a role in GLT8D3's activation context. | ||||||